Cynthia Chen

Cynthia Chen, PhD, serves as Managing Director at StemPoint Capital LP since January 2025. Prior to this role, Chen worked as a Biotech Investment Analyst at T. Rowe Price from November 2021 to January 2025 and as an Equity Research Associate specializing in Biotechnology at Cowen and Company from November 2019 to October 2021. Chen's academic background includes a PhD in Immunology from New York University, where research work was conducted as a Graduate Research Assistant from July 2013 to November 2019. Additional experience includes positions as a Senior Account Executive at Spectrum, a Senior Project Associate at RESULTS and RESULTS Educational Fund, a Graduate Consultant for Montefiore Hospital's Bronx Nutrition and Fitness Initiative for Teens Program, and a Fellow in External Affairs at the Global Alliance for TB Drug Development. Chen holds an MPA in Health Policy from New York University and a B.S. in Microbiology, Immunology, and Molecular Genetics from UCLA.